Condition: Arrhythmia · Cardiomyopathy · Arrhythmia-induced Cardiomyopathy (AiCM) · Sponsor: Hospital Universitario 12 de Octubre
The goal of this observational study is to learn about the genetic insights of arrhythmya-induced cardiomyopathy and its clinical prognosis. The main questions it aims to answer are: I. Does patients with arrhythmia-induced cardiomyopathy have a greater proportion of genetic mutations compared with other types of cardiomyopathy or general population? II. Have the genetics any prognostic impact in patients with arrhythmia-induced cardiomyopathy?
This description comes directly from the study's public registry record.
Martín Negreira-Caamaño, MD, PhD · +34913908000 · martin.negcam@gmail.com
Daniel Rodríguez-Muñoz, MD, PhD · +34913908000 · daniel.rodriguez.mnz@gmail.com
Always discuss trial participation with your own doctor first.
| Ciudad Real General University Hospital | Ciudad Real, Castille-La Mancha, Spain | Recruiting |
| 12 de Octubre University Hospital | Madrid, Madrid, Spain | Recruiting |
| Albacete University Hospital Complex | Albacete, Spain | Not Yet Recruiting |
| Ramón y Cajal University Hospital | Madrid, Spain | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06896266